Covered recipient · General Payments record
ROBERT A INSALATA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2021
$787.85
- Reported across 49 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.65 | 10 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $45.49 | 2 |
| Amarin Pharma Inc. | $42.56 | 2 |
| Acerta Pharma LLC | $24.96 | 2 |
| ABBVIE INC. | $22.04 | 1 |
| Janssen Pharmaceuticals, Inc | $18.75 | 1 |
| GlaxoSmithKline, LLC. | $15.66 | 1 |
| Biohaven Pharmaceuticals, Inc. | $15.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $22.04 | 02/24/2021 | Food and Beverage | Undisputed | 06/30/2026 | 794915035 | CMS |
| Amarin Pharma Inc. | $21.86 | 02/08/2021 | Food and Beverage | Undisputed | 06/30/2026 | 815348047 | CMS |
| Amarin Pharma Inc. | $20.70 | 03/22/2021 | Food and Beverage | Undisputed | 06/30/2026 | 815285883 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.62 | 01/28/2021 | Food and Beverage | Undisputed | 06/30/2026 | 829868287 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.34 | 03/29/2021 | Food and Beverage | Undisputed | 06/30/2026 | 829539827 | CMS |
| Biohaven Pharmaceuticals, Inc. | $15.19 | 04/06/2021 | Food and Beverage | Undisputed | 06/30/2026 | 852523831 | CMS |
| GlaxoSmithKline, LLC. | $15.66 | 03/22/2021 | Food and Beverage | Undisputed | 06/30/2026 | 802330851 | CMS |
| Janssen Pharmaceuticals, Inc | $18.75 | 03/01/2021 | Food and Beverage | Undisputed | 06/30/2026 | 788102333 | CMS |
| Lilly USA, LLC | $22.83 | 01/21/2021 | Food and Beverage | Undisputed | 06/30/2026 | 818693199 | CMS |
| Lilly USA, LLC | $22.66 | 04/05/2021 | Food and Beverage | Undisputed | 06/30/2026 | 818734765 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.